Detectable in a wide range of cells [10,11], its reduced expression in some malignant tumours, coupled with the reversion of the transformed phenotype when CD148 function is restored, implies a role as a tumour suppressor [12-14]. The gene discussed is PTPRJ; the disease is neoplasm.